CLOS
KURA icon

Compagnie Lombard Odier SCmA’s Kura Oncology KURA Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-104,293
Closed -$2.95M – 664
2021
Q1 		$2.95M Buy
+104,293
New +$3.3M 0.07% 133

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Compagnie Lombard Odier SCmA's KURA Position: Q2 2021 in Review

Compagnie Lombard Odier SCmA sold out of Kura Oncology (KURA) in Q2 2021, closing a stake of 104,293 shares — an estimated $2.95M sold.

Compagnie Lombard Odier SCmA first reported a position in KURA in Q1 2021 and held it in 1 quarter. The position peaked at $2.95M in Q1 2021. 171 funds tracked by Wall St. Rank hold KURA as of Q2 2021.

  • Compagnie Lombard Odier SCmA reported no remaining Kura Oncology position as of Q2 2021 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 104,293 Kura Oncology shares in Q2 2021, an estimated $2.95M.
  • Compagnie Lombard Odier SCmA first reported a position in Kura Oncology in Q1 2021 and held it in 1 quarter.
  • Compagnie Lombard Odier SCmA's Kura Oncology position peaked at $2.95M in Q1 2021.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2021.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2021, filed 15 Jul 2021.